AIM ImmunoTech, Inc.
(NYSE Amex Equities : HEB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.35%198.301.3%$525.45m
GILDGilead Sciences, Inc.
1.41%66.890.9%$355.47m
ALXNAlexion Pharmaceuticals, Inc.
0.95%106.672.0%$330.88m
ILMNIllumina, Inc.
0.55%306.873.5%$317.65m
BIIBBiogen Inc.
2.54%241.601.3%$313.83m
CELGCelgene Corporation
0.42%99.371.3%$295.81m
VRTXVertex Pharmaceuticals Incorporated
1.74%179.211.9%$177.79m
AAgilent Technologies, Inc.
0.65%78.581.6%$177.01m
REGNRegeneron Pharmaceuticals, Inc.
3.20%295.312.6%$171.70m
SRPTSarepta Therapeutics, Inc.
-2.30%83.4014.6%$141.91m
EXASExact Sciences Corporation
-0.30%103.1024.1%$138.35m
ACADACADIA Pharmaceuticals Inc.
-0.91%41.3013.9%$124.30m
INCYIncyte Corporation
2.52%80.092.5%$87.35m
ALDRAlder Biopharmaceuticals, Inc.
0.05%18.6710.2%$76.45m
BMRNBioMarin Pharmaceutical Inc.
-0.32%75.764.3%$75.38m

Company Profile

AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.